Green L L, Hardy M C, Maynard-Currie C E, Tsuda H, Louie D M, Mendez M J, Abderrahim H, Noguchi M, Smith D H, Zeng Y, David N E, Sasai H, Garza D, Brenner D G, Hales J F, McGuinness R P, Capon D J, Klapholz S, Jakobovits A
Cell Genesys, Inc., Foster City, California 94404.
Nat Genet. 1994 May;7(1):13-21. doi: 10.1038/ng0594-13.
We describe a strategy for producing human monoclonal antibodies in mice by introducing large segments of the human heavy and kappa light chain loci contained on yeast artificial chromosomes into the mouse germline. Such mice produce a diverse repertoire of human heavy and light chains, and upon immunization with tetanus toxin have been used to derive antigen-specific, fully human monoclonal antibodies. Breeding such animals with mice engineered by gene targeting to be deficient in mouse immunoglobulin (Ig) production has led to a mouse strain in which high levels of antibodies are produced, mostly comprised of both human heavy and light chains. These strains should provide insight into the adoptive human antibody response and permit the development of fully human monoclonal antibodies with therapeutic potential.
我们描述了一种在小鼠中产生人单克隆抗体的策略,即通过将酵母人工染色体上包含的人重链和κ轻链基因座的大片段引入小鼠种系。此类小鼠可产生多种人重链和轻链,在用破伤风毒素免疫后,已被用于获得抗原特异性的、完全人源的单克隆抗体。将这些动物与经基因靶向工程改造而缺乏小鼠免疫球蛋白(Ig)产生的小鼠进行杂交,已培育出一种能产生高水平抗体的小鼠品系,这些抗体大多由人重链和轻链组成。这些品系应能深入了解人抗体的过继性反应,并有助于开发具有治疗潜力的完全人源单克隆抗体。